Virtu Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-4,815
Closed -$678K – 1523
2019
Q2
$678K Buy
+4,815
New +$664K 0.04% 422
2017
Q4
– Sell
-2,055
Closed -$255K – 2524
2017
Q3
$255K Buy
+2,055
New +$243K 0.01% 1556
2016
Q2
– Sell
-29,018
Closed -$2.54M – 423
2016
Q1
$2.54M Buy
+29,018
New +$2.56M 0.35% 77
2015
Q4
– Sell
-18,743
Closed -$1.9M – 381
2015
Q3
$1.9M Buy
+18,743
New +$2.23M 0.25% 87
2015
Q2
– Sell
-9,885
Closed -$1.17M – 335
2015
Q1
$1.17M Sell
9,885
-8,285
-46% -$937K 0.13% 112
2014
Q4
$1.85M Buy
+18,170
New +$1.77M 0.23% 93
2014
Q3
– Sell
-3,543
Closed -$292K – 306
2014
Q2
$292K Sell
3,543
-48,430
-93% -$3.7M 0.04% 243
2014
Q1
$3.99M Buy
+51,973
New +$4.05M 0.55% 39
2013
Q3
– Sell
-3,936
Closed -$229K – 287
2013
Q2
$229K Buy
+3,936
New +$225K 0.02% 244

Other funds holding FBT

Virtu Financial's FBT Position: Q3 2019 in Review

Virtu Financial sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2019, closing a stake of 4,815 shares — an estimated $678K sold.

Virtu Financial first reported a position in FBT in Q2 2013 and held it in 9 quarters. The position peaked at $3.99M in Q1 2014. 188 funds tracked by Wall St. Rank hold FBT as of Q3 2019.

  • Virtu Financial reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2019 after selling out during the quarter.
  • Virtu Financial sold 4,815 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2019, an estimated $678K.
  • Virtu Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 9 quarters.
  • Virtu Financial's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.99M in Q1 2014.
  • 188 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2019.

Based on Virtu Financial's 13F filing for Q3 2019, filed 20 Nov 2019.